Market Place
Sourcing Support
Turn Biotechnologies Acquires ARMMs Vesicular Technology
26 Mar 2025 //
PR NEWSWIRE
Vesigen Highlights Non-Viral Delivery Platform Data At ASGCT, ARVO 2024
13 May 2024 //
BUSINESSWIRE
Vesigen: ARMM Ophthalmology Data At ARVO 2024
01 May 2024 //
BUSINESSWIRE
Vesigen Presenting Engineered ARMMs Tech At ASGCT 2024
22 Apr 2024 //
BUSINESSWIRE
Vesigen to Present at the 2024 Cell and Gene Meeting on the Med
03 Apr 2024 //
BUSINESSWIRE
Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology
19 Oct 2023 //
BUSINESSWIRE
Vesigen Highlights New Data on Non-Viral Delivery Platform
07 Sep 2023 //
BUSINESSWIRE
Vesigen Highlights Platform for Non-Viral Delivery of Gene Editors
22 May 2023 //
BUSINESSWIRE
Vesigen Therapeutics Announces Presentations at the ASGCT 26th Annual Meeting
02 May 2023 //
BUSINESSWIRE
Vesigen Therapeutics, Inc. Announces Expansion of Scientific Advisory Board
07 Feb 2023 //
BUSINESSWIRE
Vesigen Therapeutics Names Rakhshita Dhar to Board of Directors
30 Jan 2023 //
BUSINESSWIRE
Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer
11 Apr 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.